In December 2025, a compelling article was published in the US-based international magazine World Health Leaders. The care pathway and this website are now being used increasingly worldwide. This article explains why this care pathway was developed and how it can help everyone involved improve the care of heart failure patients. Teamwork makes the dream […]

Beyonttra (acoramidis) 356 mg is reimbursed in Belgium from January 1, 2026, for the treatment of wild-type or hereditary transthyretin amyloidosis in adults with cardiac ATTR cardiomyopathy who meet the reimbursement criteria. Acoramidis is a potent, nearly complete transthyretin (TTR) stabilizer (≥ 90% TTR stabilization) and thus prevents further deposition of TTR monomers in the […]

The largest annual cardiology event in Belgium, the BSC Congress, will take place on January 29 and 30, 2026. It will be an in-person event at Brussels EXPO, with all necessary measures for a safe meeting environment. https://www.bscardio.be/congress/congress-2026/

HFA European Heart Failure Association congress 2026, Barcelona, Spain, 09 - 12 May 2026 https://www.escardio.org/Congresses-Events/Heart-Failure/About-the-congress

Since 1 January 2025, a legal framework and reimbursement for part of the telemonitoring of patients with heart failure in hospitals that have been recognised for this purpose by the RIZIV. This concerns the telemonitoring of the clinical parameters weight, blood pressure and heart rate or of invasively measured pulmonary pressures (via the CardioMEMS or […]

This new website provides everyone involved with patients with heart failure with the necessary information and practical points of attention. Good education and cooperation between primary and secondary care are crucial. The care pathway was developed by the Belgian Heart Failure Working Group (BWGHF) and is supported by Domus Medica.